The estimated Net Worth of John B Ph D Md Simpson is at least $3.96 Million dollars as of 13 November 2017. John Simpson owns over 1,074,130 units of Avinger Inc stock worth over $63,984 and over the last 9 years John sold AVGR stock worth over $3,894,438.
John has made over 5 trades of the Avinger Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently John sold 1,074,130 units of AVGR stock worth $268,533 on 13 November 2017.
The largest trade John's ever made was selling 1,074,130 units of Avinger Inc stock on 13 November 2017 worth over $268,533. On average, John trades about 132,924 units every 72 days since 2015. As of 13 November 2017 John still owns at least 55,159 units of Avinger Inc stock.
You can see the complete history of John Simpson stock trades at the bottom of the page.
John's mailing address filed with the SEC is C/O AVINGER, INC., 400 CHESAPEAKE DRIVE, , REDWOOD CITY, CA, 94063.
Over the last 10 years, insiders at Avinger Inc have traded over $4,931,811 worth of Avinger Inc stock and bought 65,650 units worth $291,405 . The most active insiders traders include John B Ph D Md Simpson, James Cullen, and Jeffrey M Soinski. On average, Avinger Inc executives and independent directors trade stock every 57 days with the average trade being worth of $43,246. The most recent stock trade was executed by Nabeel Paul Subainati on 22 March 2023, trading 417 units of AVGR stock currently worth $484.
avinger, inc. is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems for the treatment of patients with peripheral artery disease (pad). pad is characterized by a build-up of plaque in the arteries that supply blood to the arms and legs. the company’s mission is to radically change the way vascular disease is treated through the introduction of products based on its lumivascular platform, the only intravascular image-guided system of therapeutic catheters available in this market. avinger’s current lumivascular products include the lightbox imaging console, the ocelot family of catheters, which are designed to penetrate total arterial blockages, known as chronic total occlusions, or ctos, and pantheris, the first-ever image- guided atherectomy device, designed to precisely remove arterial plaque in pad patients.
Avinger Inc executives and other stock owners filed with the SEC include: